IL2RA and myeloid sarcoma: The CSF CD25 concentration (Figure 3B) did not seem to be effective to separate MS from NMOSD/MOGAD (median CSF CD25 of 20.5 vs. 27.6 pg/ml for MS and NMOSD/MOGAD, respectively, p = 0.755).